颅内动脉瘤破裂前炎症标志物的系列变化
本回顾性研究纳入基线未破裂动脉瘤患者43例(27例至少5年未破裂,16例随访中破裂),并另设32例急性动脉瘤性蛛网膜下腔出血患者作为破裂后对照。结果显示,破裂前最后30天内中性粒细胞与淋巴细胞比值(NLR)和系统免疫炎症指数(SII)显著升高,但基线与第一年数值无法判别后续破裂。
要点
- 破裂前30天内NLR与SII显著升高,提示晚期炎症阶段。
- 16例破裂患者中13例在该期出现症状,13例破裂时影像显示动脉瘤不规则。
- 基线与第一年标志物值不能预测后续破裂,预后价值尚未确立。
核心结论
- NLR与SII升高刻画了该选定队列中晚期、常伴症状的破裂前炎症阶段,而非提供前瞻性破裂预测。
- 系列炎症标志物变化的预后价值尚未确立,需前瞻性标准化采样研究评估。
研究设计与样本
- 回顾性研究,主纵向队列为基线记录为未破裂动脉瘤的43例患者:27例至少5年未破裂(组1),16例随访中破裂(组2)。
- 另纳入32例急性动脉瘤性蛛网膜下腔出血患者(组3)作为破裂后对照。
- 对主队列纵向评估NLR、SII及动脉瘤形态。
主要发现
- 组1与组2基线NLR和SII相似。
- 破裂前最后30天内,NLR从1.7 ± 0.2升至3.4 ± 0.5,SII从418 ± 43升至862 ± 109(均p < 0.001)。
- 16例中有13例在该期出现症状。
- 破裂时影像显示16例中13例(81%)动脉瘤不规则,而基线时均为规则;该变化的时间点无法确定。
- 1年界标分析中,基线与第一年数值均不能判别后续破裂。
临床怎么用
- 对未破裂动脉瘤随访中出现的NLR、SII升高及新发症状应保持警惕,但不可据此单独预测破裂。
- 破裂时形态不规则与生物标志物采样不同步,判读时需结合影像与临床。
- 系列标志物变化目前仅属研究性指标,尚不能替代现有破裂风险评估。
局限性
- 为回顾性、单中心、样本量有限的选择性队列。
- 破裂前标志物变化的时间关系与采样时点无法精确对应。
- 形态变化与标志物采样不同步,变化时间点无法确定。
- 缺乏前瞻性标准化采样验证,预后价值未确立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Small aneurysms classified as low risk by the PHASES score may become unstable during surveillance. We evaluated within-patient changes in the neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) during the late clinical phase preceding aneurysm rupture. METHODS: This retrospective study centered on a primary longitudinal cohort of 43 patients with an aneurysm documented as unruptured at baseline: 27 remained rupture-free for at least 5 years (Group 1) and 16 subsequently ruptured during follow-up (Group 2). An additional 32 patients presenting with acute aneurysmal subarachnoid hemorrhage (aSAH; Group 3) were included as a secondary post-rupture comparator. NLR, SII, and aneurysm morphology were assessed longitudinally in the primary cohort. RESULTS: Baseline NLR and SII were similar in Groups 1 and 2. During the final 30 days before rupture, NLR increased from 1.7 ± 0.2 to 3.4 ± 0.5 and SII from 418 ± 43 to 862 ± 109 (both p < 0.001). Thirteen of 16 patients were symptomatic during this period. At rupture-time imaging, 13 of 16 aneurysms (81%)were irregular, whereas all were regular at baseline; the timing of this change could not be established. In a 1-year landmark analysis, baseline and first-year values did not discriminate subsequent rupture. CONCLUSIONS: Rising NLR and SII characterized a late, frequently symptomatic pre-rupture inflammatory phase in this selected cohort rather than providing prospective rupture prediction. Rupture-time morphological irregularity was complementary but not synchronized with biomarker sampling. The prognostic value of serial biomarker changes remains unestablished and requires evaluation in prospective studies with standardized sampling.
引用
- Yavuz AY, Sahin C, Percinoglu G, et al. Serial Changes in Inflammatory Biomarkers Preceding Intracranial Aneurysm Rupture. World Neurosurg. 2026. PMID: 42962817. doi:10.1016/j.wneu.2026.125463
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。